$155 Million is the total value of Birchview Capital, LP's 67 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 14.1% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
BMY | Sell | BRISTOL-MYERS SQUIBB CO | $47,767,000 | +1.4% | 766,106 | -3.8% | 30.80% | -3.9% |
AXDX | ACCELERATE DIAGNOSTICS INC | $11,732,000 | -10.4% | 2,252,388 | 0.0% | 7.57% | -15.1% | |
AZYO | Buy | AZIYO BIOLOGICS INC | $8,352,000 | +2300.0% | 1,417,923 | +2735.8% | 5.39% | +2172.6% |
QDEL | QUIDEL CORP | $8,057,000 | -4.4% | 59,684 | 0.0% | 5.20% | -9.4% | |
NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $7,597,000 | -1.2% | 89,200 | +11.2% | 4.90% | -6.4% |
FHTX | FOGHORN THERAPEUTICS INC | $7,184,000 | +64.2% | 314,143 | 0.0% | 4.63% | +55.6% | |
BDSX | Buy | BIODESIX INC | $6,627,000 | -27.0% | 1,252,753 | +13.4% | 4.27% | -30.9% |
ACAD | ACADIA PHARMACEUTICALS INC | $4,654,000 | +40.5% | 199,400 | 0.0% | 3.00% | +33.1% | |
UTHR | UNITED THERAPEUTICS CORP | $3,889,000 | +17.1% | 18,000 | 0.0% | 2.51% | +10.9% | |
BIIB | BIOGEN INC | $3,023,000 | -15.2% | 12,600 | 0.0% | 1.95% | -19.7% | |
ALBO | ALBIREO PHARMA INC | $2,632,000 | -25.4% | 113,000 | 0.0% | 1.70% | -29.3% | |
MASI | MASIMO CORP | $2,342,000 | +8.1% | 8,000 | 0.0% | 1.51% | +2.4% | |
ARNA | ARENA PHARMACEUTICALS INC | $2,045,000 | +56.1% | 22,000 | 0.0% | 1.32% | +48.0% | |
PRTA | PROTHENA CORP PLC | $1,988,000 | -30.7% | 40,247 | 0.0% | 1.28% | -34.3% | |
INBX | New | INHIBRX INC | $1,747,000 | – | 40,000 | +100.0% | 1.13% | – |
CLR | CONTINENTAL RESOURCES INC | $1,728,000 | -3.0% | 38,600 | 0.0% | 1.11% | -8.1% | |
BHVN | Buy | BIOHAVEN PHARMACEUTICAL HOLDING CO LTD | $1,654,000 | +19.1% | 12,000 | +20.0% | 1.07% | +12.9% |
KPTI | KARYOPHARM THERAPEUTICS INC | $1,582,000 | +10.5% | 246,000 | 0.0% | 1.02% | +4.7% | |
HROW | HARROW HEALTH INC | $1,555,000 | -5.0% | 180,000 | 0.0% | 1.00% | -9.9% | |
IMGN | IMMUNOGEN INC | $1,410,000 | +30.9% | 190,000 | 0.0% | 0.91% | +24.0% | |
ETRN | EQUITRANS MIDSTREAM CORPORATIO | $1,376,000 | +2.0% | 133,050 | 0.0% | 0.89% | -3.4% | |
NKTR | Buy | NEKTAR THERAPEUTICS | $1,351,000 | +4.5% | 100,000 | +38.9% | 0.87% | -1.0% |
PTGX | PROTAGONIST THERAPEUTICS INC | $1,300,000 | +93.2% | 38,000 | 0.0% | 0.84% | +83.0% | |
ARVN | ARVINAS INC | $1,232,000 | -0.1% | 15,000 | 0.0% | 0.79% | -5.4% | |
ALKS | ALKERMES PLC | $1,163,000 | -24.6% | 50,000 | 0.0% | 0.75% | -28.5% | |
OVV | OVINTIV INC | $1,153,000 | +2.6% | 34,200 | 0.0% | 0.74% | -2.7% | |
CYTK | CYTOKINETICS INC | $1,140,000 | +27.5% | 25,000 | 0.0% | 0.74% | +20.9% | |
GOSS | Buy | GOSSAMER BIO INC | $1,131,000 | +124.9% | 100,000 | +150.0% | 0.73% | +113.2% |
AMRN | AMARIN CORP PLCspons adr new | $1,011,000 | -33.9% | 300,000 | 0.0% | 0.65% | -37.4% | |
CORT | CORCEPT THERAPEUTICS INC | $990,000 | +0.6% | 50,000 | 0.0% | 0.64% | -4.8% | |
VNDA | Sell | VANDA PHARMACEUTICALS INC | $941,000 | -31.4% | 60,000 | -25.0% | 0.61% | -34.9% |
BLUE | BLUEBIRD BIO INC | $839,000 | -47.7% | 84,000 | 0.0% | 0.54% | -50.5% | |
PGNY | PROGYNY INC | $755,000 | -10.1% | 15,000 | 0.0% | 0.49% | -14.9% | |
CCXI | Sell | CHEMOCENTRYX INC | $728,000 | +70.1% | 20,000 | -20.0% | 0.47% | +61.2% |
New | 2SEVENTY BIO INC | $718,000 | – | 27,999 | +100.0% | 0.46% | – | |
CGEM | CULLINAN ONCOLOGY INC | $696,000 | -31.6% | 45,114 | 0.0% | 0.45% | -35.2% | |
PXD | PIONEER NATURAL RESOURCES CO | $691,000 | +9.2% | 3,800 | 0.0% | 0.45% | +3.5% | |
ZNTL | ZENTALIS PHARMACEUTICALS INC | $672,000 | +26.1% | 8,000 | 0.0% | 0.43% | +19.3% | |
AVEO | Buy | AVEO PHARMACEUTICALS INC | $657,000 | +166.0% | 140,000 | +250.0% | 0.42% | +152.4% |
NARI | INARI MEDICAL INC | $639,000 | +12.5% | 7,000 | 0.0% | 0.41% | +6.5% | |
APLS | APELLIS PHARMACEUTICALS INC | $567,000 | +43.2% | 12,000 | 0.0% | 0.37% | +36.1% | |
KALV | KALVISTA PHARMACEUTICALS INC | $529,000 | -24.2% | 40,000 | 0.0% | 0.34% | -28.2% | |
CFRX | CONTRAFECT CORP | $526,000 | -35.1% | 200,000 | 0.0% | 0.34% | -38.5% | |
New | VENTYX BIOSCIENCES INC | $497,000 | – | 25,000 | +100.0% | 0.32% | – | |
XNCR | XENCOR INC | $493,000 | +22.6% | 12,300 | 0.0% | 0.32% | +16.1% | |
IRTC | IRHYTHM TECHNOLOGIES INC | $471,000 | +101.3% | 4,000 | 0.0% | 0.30% | +91.2% | |
FOLD | AMICUS THERAPEUTICS INC | $439,000 | +20.9% | 38,000 | 0.0% | 0.28% | +14.6% | |
GTHX | G1 THERAPEUTICS INC | $408,000 | -24.0% | 40,000 | 0.0% | 0.26% | -27.9% | |
TPTX | TURNING POINT THERAPEUTICS INC | $382,000 | -28.1% | 8,000 | 0.0% | 0.25% | -31.9% | |
SLNO | SOLENO THERAPEUTICS INC | $360,000 | -55.6% | 876,899 | 0.0% | 0.23% | -58.0% | |
STOK | STOKE THERAPEUTICS INC | $360,000 | -5.8% | 15,000 | 0.0% | 0.23% | -10.8% | |
KNSA | KINIKSA PHARMACEUTICALS LTD | $353,000 | +3.2% | 30,000 | 0.0% | 0.23% | -2.1% | |
SILK | New | SILK ROAD MEDICAL INC | $341,000 | – | 8,000 | +100.0% | 0.22% | – |
IFRX | INFLARX NV | $333,000 | +84.0% | 70,000 | 0.0% | 0.22% | +74.8% | |
TGTX | TG THERAPEUTICS INC | $285,000 | -42.9% | 15,000 | 0.0% | 0.18% | -45.9% | |
BCRX | BIOCRYST PHARMACEUTICALS INC | $277,000 | -3.5% | 20,000 | 0.0% | 0.18% | -8.2% | |
ISEE | IVERIC BIO INC | $251,000 | +2.9% | 15,000 | 0.0% | 0.16% | -2.4% | |
PFE | New | PFIZER INC | $236,000 | – | 4,000 | +100.0% | 0.15% | – |
LSF | Buy | LAIRD SUPERFOOD INC | $235,000 | -12.0% | 18,000 | +28.6% | 0.15% | -16.5% |
AKBA | AKEBIA THERAPEUTICS INC | $226,000 | -21.5% | 100,000 | 0.0% | 0.15% | -25.5% | |
AWH | ASPIRA WOMENS HEALTH INC | $182,000 | -45.7% | 103,104 | 0.0% | 0.12% | -48.7% | |
ANGN | ANGION BIOMEDICA CORP | $158,000 | -70.2% | 54,392 | 0.0% | 0.10% | -71.7% | |
SIEN | SIENTRA INC | $147,000 | -35.8% | 40,000 | 0.0% | 0.10% | -39.1% | |
New | DOCGO INC | $94,000 | – | 10,000 | +100.0% | 0.06% | – | |
YTEN | Sell | YIELD10 BIOSCIENCE INC | $92,000 | -18.6% | 18,750 | -0.2% | 0.06% | -23.4% |
CNCE | CONCERT PHARMACEUTICALS INC | $63,000 | -3.1% | 20,000 | 0.0% | 0.04% | -6.8% | |
TXMD | Sell | THERAPEUTICSMD INC | $18,000 | -75.7% | 50,000 | -50.0% | 0.01% | -76.0% |
ARQT | Exit | ARCUTIS BIOTHERAPEUTICS INC | $0 | – | -9,000 | -100.0% | -0.15% | – |
PROG | Exit | PROGENITY INC | $0 | – | -270,000 | -100.0% | -0.28% | – |
XLRN | Exit | ACCELERON PHARMA INC | $0 | – | -10,672 | -100.0% | -1.25% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ACCELERATE DIAGNOSTICS INC | 36 | Q3 2023 | 34.6% |
QUIDELORTHO CORP | 36 | Q3 2023 | 8.6% |
MASIMO CORP | 36 | Q3 2023 | 2.2% |
PIONEER NATURAL RESOURCES CO (PXD) | 36 | Q3 2023 | 0.7% |
XENCOR INC | 35 | Q3 2023 | 0.4% |
NEUROCRINE BIOSCIENCES INC | 33 | Q3 2023 | 7.4% |
CORCEPT THERAPEUTICS INC | 32 | Q3 2023 | 1.2% |
BIOGEN INC | 31 | Q2 2022 | 3.1% |
CONTRAFECT CORP | 30 | Q3 2022 | 1.6% |
YIELD10 BIOSCIENCE INC | 26 | Q3 2023 | 0.6% |
View Birchview Capital, LP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
SOLENO THERAPEUTICS INC | March 19, 2019 | 742,635 | 2.3% |
YIELD10 BIOSCIENCE, INC. | December 29, 2017 | 186,079 | 2.2% |
HANSEN MEDICAL INC | February 16, 2016 | ? | ? |
METABOLIX, INC. | June 23, 2015 | 749,696 | 2.8% |
View Birchview Capital, LP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
3/A | 2024-02-20 |
4/A | 2024-02-20 |
SC 13G/A | 2024-02-20 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-08 |
13F-HR | 2023-05-12 |
SC 13G/A | 2023-04-07 |
4 | 2023-03-27 |
3 | 2023-02-13 |
View Birchview Capital, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.